Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial

RD Johnston, Stephen; Kilburn, Lucy S; Ellis, Paul; Dodwell, David; Cameron, David; Hayward, Larry; Im, Young-Hyuck; Braybrooke, Jeremy P; Brunt, A Murray; Cheung, Kwok-Leung; Jyothirmayi, Rema; Robinson, Anne; Wardley, Andrew M; Wheatley, Duncan; Howell, Anthony; Coombes, Gill; Sergenson, Nicole; Sin, Hui-Jung; Folkerd, Elizabeth; Dowsett, Mitch; Bliss, Prof Judith M; investigators, SoFEA

doi:10.1016/S1470-2045(13)70322-X

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial

RD Johnston, Stephen; Kilburn, Lucy S; Ellis, Paul; Dodwell, David; Cameron, David; Hayward, Larry; Im, Young-Hyuck; Braybrooke, Jeremy P; Brunt, A Murray; Cheung, Kwok-Leung; Jyothirmayi, Rema; Robinson, Anne; Wardley, Andrew M; Wheatley, Duncan; Howell, Anthony; Coombes, Gill; Sergenson, Nicole; Sin, Hui-Jung; Folkerd, Elizabeth; Dowsett, Mitch; Bliss, Prof Judith M; investigators, SoFEA

Authors

Stephen RD Johnston

Lucy S Kilburn

Paul Ellis

David Dodwell

David Cameron

Larry Hayward

Young-Hyuck Im

Jeremy P Braybrooke

Professor Adrian Brunt m.brunt@keele.ac.uk

Kwok-Leung Cheung

Rema Jyothirmayi

Anne Robinson

Andrew M Wardley

Duncan Wheatley

Anthony Howell

Gill Coombes

Nicole Sergenson

Hui-Jung Sin

Elizabeth Folkerd

Mitch Dowsett

Prof Judith M Bliss

SoFEA investigators

Citation

RD Johnston, S., Kilburn, L. S., Ellis, P., Dodwell, D., Cameron, D., Hayward, L., …investigators, S. (2013). Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial. Lancet Oncology, 14(10), 989-998. https://doi.org/10.1016/S1470-2045%2813%2970322-X

Journal Article Type	Article
Online Publication Date	Jul 29, 2013
Publication Date	2013-09
Deposit Date	Aug 29, 2023
Journal	LANCET ONCOLOGY
Print ISSN	1470-2045
Publisher	Elsevier
Peer Reviewed	Peer Reviewed
Volume	14
Issue	10
Pages	989-998
DOI	https://doi.org/10.1016/S1470-2045%2813%2970322-X

Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial. (2023)
Journal Article

Hypofractionation: The standard for external beam breast irradiation (2023)
Journal Article

Data from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results (2023)
Dataset

Downloadable Citations

HTML

BIB

RTF

Authors

Citation

You might also like

Downloadable Citations